Veröffentlichungen

Recurrent inversion polymorphisms in humans associate with genetic instability and genomic disorders

D. Porubsky
W. Höps
H. Ashraf
P.H. Hsieh
B. Rodriguez-Martin
F. Yilmaz
J. Ebler
P. Hallast
F.A.M. Maggiolini
W.T. Harvey
B. Henning
P.A. Audano
D.S. Gordon
P. Ebert
P. Hasenfeld
E. Benito
Q. Zhu
C. Lee
F. Antonacci
M. Steinrücken
C.R. Beck
A.D. Sanders
T. Marschall
E.E. Eichler
J.O. Korbel

Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single cell transcriptomics

E. Wyler
J.M. Adler
K. Eschke
G. Teixeira Alves
S. Peidli
F. Pott
J. Kazmierski
L. Michalick
O. Kershaw
J. Bushe
S. Andreotti
P. Pennitz
A. Abdelgawad
D. Postmus
C. Goffinet
J. Kreye
S.M. Reincke
H. Prüss
N. Blüthgen
A.D. Gruber
W.M. Kuebler
M. Witzenrath
M. Landthaler
G. Nouailles
J. Trimpert

Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody-associated disease

J.J. Chen
S. Huda
Y. Hacohen
M. Levy
I. Lotan
A. Wilf-Yarkoni
H. Stiebel-Kalish
M.A. Hellmann
E.S. Sotirchos
A.D. Henderson
S.J. Pittock
M.T. Bhatti
E.R. Eggenberger
M. Di Nome
H.J. Kim
S.H. Kim
A. Saiz
F. Paul
R.C. Dale
S. Ramanathan
J. Palace
V. Camera
M.I. Leite
B.L. Lam
J.L. Bennett
S. Mariotto
D. Hodge
B. Audoin
E. Maillart
R. Deschamps
J. Pique
E.P. Flanagan
R. Marignier

Efficacy and safety of masitinib in progressive forms of multiple sclerosis: a randomized, phase 3, clinical trial

P. Vermersch
L. Brieva-Ruiz
R.J. Fox
F. Paul
L. Ramio-Torrenta
M. Schwab
A. Moussy
C. Mansfield
O. Hermine
M. Maciejowski

Effect of sunitinib treatment on skin sodium accumulation in patients with renal cancer: a pilot study

L. Marko
A. Dörr
P. Linz
A.H. van den Meiracker
I.M. Garrelds
T. Kuehne
R. Dechend
A.H.J. Danser
A. Flörcken
D.N. Müller

01. Mai 2022 in Neurol Neuroimmunol Neuroinflamm

Choroid plexus volume in multiple sclerosis vs neuromyelitis optica spectrum disorder: a retrospective, cross-sectional analysis

J. Müller
T. Sinnecker
M.J. Wendebourg
R. Schläger
J. Kuhle
S. Schädelin
P. Benkert
T. Derfuss
P. Cattin
C. Jud
F. Spiess
M. Amann
T. Lincke
M. Barakovic
A. Cagol
C. Tsagkas
K. Parmar
A.K. Pröbstel
S. Reimann
S. Asseyer
A. Duchow
A. Brandt
K. Ruprecht
N. Hadjikhani
S. Fukumoto
M. Watanabe
K. Masaki
T. Matsushita
N. Isobe
J.I. Kira
L. Kappos
J. Würfel
C. Granziera
F. Paul
Ö. Yaldizli

Targeted analysis of cell-free circulating tumor DNA is suitable for early relapse and actionable target detection in patients with neuroblastoma

M. Lodrini
J. Graef
T.M. Thole-Kliesch
K. Astrahantseff
A. Sprüssel
M. Grimaldi
C. Peitz
R.B. Linke
J.F. Hollander
E. Lankes
A. Künkele
L. Oevermann
G. Schwabe
J. Fuchs
A. Szymansky
J.H. Schulte
P. Hundsdoerfer
C. Eckert
H. Amthauer
A. Eggert
H.E. Deubzer

Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase in B cell lymphomas

C. Lopez
N. Schleussner
S.H. Bernhart
K. Kleinheinz
S. Sungalee
H.L. Sczakiel
H. Kretzmer
U.H. Toprak
S. Glaser
R. Wagener
O. Ammerpohl
S. Bens
M. Giefing
J.C.G. Sanchez
G. Apic
D. Hubschmann
M. Janz
M. Kreuz
A. Mottok
J.M. Müller
J. Seufert
S. Hoffmann
J.O. Korbel
R.B. Russell
R. Schule
L. Trumper
W. Klapper
B. Radlwimmer
P. Lichter
R. Kuppers
M. Schlesner
S. Mathas
R. Siebert

Different impact of gadopentetate and gadobutrol on inflammation-promoted retention and toxicity of gadolinium within the mouse brain

L. Anderhalten
R.V. Silva
A. Morr
S. Wang
A. Smorodchenko
J. Saatz
H. Traub
S. Mueller
P. Boehm-Sturm
Y. Rodriguez-Sillke
D. Kunkel
J. Hahndorf
F. Paul
M. Taupitz
I. Sack
C. Infante-Duarte

Diagnostic efficacy of the magnetic resonance T1w/T2w ratio for the middle cerebellar peduncle in multiple system atrophy and spinocerebellar ataxia: a preliminary study

J. Wang
A. Sugiyama
H. Yokota
S. Hirano
G. Cooper
H. Mukai
K. Ohira
K. Koide
S. Ito
C. Finke
A.U. Brandt
F. Paul
S. Kuwabara